2022
Patient-level and external factors in the use of drug-coated balloons and drug-eluting stents in femoropopliteal endovascular interventions
Castro-Dominguez Y, Smolderen KG, Pichert M, Alabi O, Romain G, Huang J, Lee M, Ahmed Z, Peri-Okonny PA, Arham A, Brice A, Chaar CO, Stacy MR, Mena-Hurtado C. Patient-level and external factors in the use of drug-coated balloons and drug-eluting stents in femoropopliteal endovascular interventions. Journal Of Vascular Surgery 2022, 76: 1675-1680. PMID: 35868423, DOI: 10.1016/j.jvs.2022.06.093.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsDrug-eluting stentsBare metal stentsDES useFemoropopliteal endovascular interventionEndovascular interventionMedian odds ratioFemoropopliteal diseaseLesion characteristicsPrimary treatmentChronic kidney disease stage 4Adjusted median odds ratioVascular Quality Initiative registryAppropriate use guidelinesPrior anticoagulant usePatient-level factorsPoor functional statusTrans-Atlantic InterPlain balloon angioplastyPatient-level characteristicsFavorable patency ratesHierarchical logistic regression modelsLogistic regression modelsMeta-analysis publicationsRutherford classification
2021
PREDICTORS OF DRUG-COATED BALLOON AND DRUG-ELUTING STENT USE IN FEMOROPOPLITEAL ENDOVASCULAR INTERVENTIONS. INSIGHTS FROM THE VASCULAR QUALITY INITIATIVE
Dominguez Y, Pichert M, Alabi O, Huang J, Arham A, Brice A, Ahmed Z, Chaar C, Peri-Okonny P, Stacy M, Smolderen K, Hurtado C. PREDICTORS OF DRUG-COATED BALLOON AND DRUG-ELUTING STENT USE IN FEMOROPOPLITEAL ENDOVASCULAR INTERVENTIONS. INSIGHTS FROM THE VASCULAR QUALITY INITIATIVE. Journal Of The American College Of Cardiology 2021, 77: 1005. DOI: 10.1016/s0735-1097(21)02364-0.Peer-Reviewed Original ResearchVascular Quality InitiativeFemoropopliteal endovascular interventionPredictors of DrugEndovascular interventionStent useQuality InitiativeDrugs